Sign In
Buy LMLLF
$0.0037
+0 (+0%)
At Close: Jun 22, 2026
PharmaDrug's Super Smart Launches Online Retail Platform in the United States
07:49am, Monday, 17'th May 2021
Toronto, Ontario--(Newsfile Corp. - May 17, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, developmen
PharmaDrug inks supply deal for the production and sale of THC oil in Germany
11:29am, Friday, 14'th May 2021
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) said it has entered into a supply agreement with a Eurozone cannabis extractor to produce medical-grade THC oil for sale under PharmaDrug's own brand. The co
PharmaDrug Signs Supply Agreement with European Cannabis Extractor for Medical Grade THC Oil to Be Sold Under PharmaDrug Brand
09:25am, Friday, 14'th May 2021
Toronto, Ontario--(Newsfile Corp. - May 14, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, developmen
PharmaDrug promotes Dr Paul Van Slyke to Chief Scientific Officer for whole group
09:36am, Thursday, 13'th May 2021
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) has named entrepreneur-scientist and experienced pharma executive Dr Paul Van Slyke as the new Chief Scientific Officer (CSO) for the group. Van Slyke previ
PharmaDrug begins preclinical studies of Cepharanthine formulation in a wide range of cancers
11:19am, Thursday, 06'th May 2021
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) announced it is starting a preclinical study of its Cepharanthine formulation in a broad range of cancers. The pharmaceutical company signed a service agreeme
Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, developmen
PharmaDrug becomes first company to receive Orphan Drug Designation for DMT from the US FDA
09:36am, Wednesday, 28'th Apr 2021
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) announced that it has received Orphan Drug Designation for its dimethyltryptamine (DMT) formulation to prevent ischemia-reperfusion injury from organ transpla
PharmaDrug Announces First FDA Orphan Drug Designation of DMT for the Prevention of Ischemia-Reperfusion Injury from Organ Transplantation
08:03am, Wednesday, 28'th Apr 2021
Toronto, Ontario--(Newsfile Corp. - April 28, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, develop
PharmaDrug signs deal to begin manufacturing potential esophageal cancer and coronavirus treatment Cepharanthine
10:06am, Tuesday, 20'th Apr 2021
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) announced it has reached an agreement with Southwest Research Institute (SwRI) to initiate clinical and non-clinical manufacturing of Cepharanthine for the co
PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Rare Cancers and Infectious Diseases
07:30am, Tuesday, 20'th Apr 2021
Toronto, Ontario--(Newsfile Corp. - April 20, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, develop
PharmaDrug teams up with leading DMT researcher Jimo Borjigin at the University of Michigan in new study collaboration
11:23am, Tuesday, 16'th Mar 2021
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) said Tuesday it is starting DMT studies through a new collaboration with the University of Michigan. The Toronto-based pharmaceutical company is teaming up
Wall Street off to a mixed start on Tuesday
11:23am, Tuesday, 16'th Mar 2021
10.30am: Proactive North America headlines: Neo Lithium Corp (CVE:NLC) (OTCQX:NTTHF) (FRA:NE2) closes its C$2.6M equity financing with Chinese investor CATL GlobeX Data Ltd (OTCQB:SWISF) (CSE:SWIS) re
PharmaDrug Provides Update on Its Annual General Meeting
05:08pm, Friday, 12'th Mar 2021
Toronto, Ontario--(Newsfile Corp. - March 12, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), will hold its Annual General Meeting ("AGM" or "Meeting") on March
PharmaDrug Announces Drug-Repurposing Expert Moshe Rogosnitzky Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board
08:00am, Tuesday, 09'th Mar 2021
Toronto, Ontario--(Newsfile Corp. - March 9, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") wholly-owned subsidiary, Sairiyo Therapeutics Inc. ("Sairiyo"), a bio
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) subsidiary Sariyo Therapeutics Inc, a biotechnology company developing the compound Cepharanthine as a treatment for cancer and other diseases, announced Thur
